Terms: = Lung cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Treatment
73 results:
1. Hyaluronic acid-based injectable formulation developed to mitigate metastasis and radiation-induced skin fibrosis in breast cancer treatment.
Wang YC; Shueng PW; Hu CY; Tung FI; Chen MH; Liu TY
Carbohydr Polym; 2024 Jul; 336():122136. PubMed ID: 38670762
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
[TBL] [Abstract] [Full Text] [Related]
3. Identification of protein signatures for lung cancer subtypes based on BPSO method.
Wang J; Wang H; Xu J; Song Q; Zhou B; Shangguan J; Xue M; Wang Y
PLoS One; 2023; 18(12):e0294243. PubMed ID: 38060494
[TBL] [Abstract] [Full Text] [Related]
4. Updates in Management of Malignant Pleural Mesothelioma.
John A; O'Sullivan H; Popat S
Curr Treat Options Oncol; 2023 Dec; 24(12):1758-1789. PubMed ID: 37975977
[TBL] [Abstract] [Full Text] [Related]
5. MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF.
Kondo N; Utsumi T; Shimizu Y; Takemoto A; Oh-Hara T; Uchibori K; Subat-Motoshi S; Ninomiya H; Takeuchi K; Nishio M; Miyazaki Y; Katayama R
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917191
[TBL] [Abstract] [Full Text] [Related]
6. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
[TBL] [Abstract] [Full Text] [Related]
7. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
[TBL] [Abstract] [Full Text] [Related]
8. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
9. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Borea F; Franczak MA; Garcia M; Perrino M; Cordua N; Smolenski RT; Peters GJ; Dziadziuszko R; Santoro A; Zucali PA; Giovannetti E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298116
[TBL] [Abstract] [Full Text] [Related]
10. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
[TBL] [Abstract] [Full Text] [Related]
11. Genomic landscape of pleural and peritoneal mesothelioma tumours.
Hiltbrunner S; Fleischmann Z; Sokol ES; Zoche M; Felley-Bosco E; Curioni-Fontecedro A
Br J Cancer; 2022 Nov; 127(11):1997-2005. PubMed ID: 36138075
[TBL] [Abstract] [Full Text] [Related]
12. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma.
Nguyen TT; Lee HS; Burt BM; Amos CI; Cheng C
Br J Cancer; 2022 Nov; 127(9):1691-1700. PubMed ID: 35999269
[TBL] [Abstract] [Full Text] [Related]
13. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V
Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016
[TBL] [Abstract] [Full Text] [Related]
14. Atezolizumab plus carboplatin and nab-paclitaxel versus carboplatin and nab-paclitaxel as treatments for Chinese, treatment-naïve, stage IV, non-squamous, non-small-cell lung cancer patients: A retrospective analysis.
Chen Y; Kang S; Yan M
Pharmacol Res Perspect; 2022 Jun; 10(3):e00941. PubMed ID: 35568997
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of Auto-Contouring and Dose Distributions for Online Adaptive Radiation Therapy of Patients With Locally Advanced lung cancers.
Mao W; Riess J; Kim J; Vance S; Chetty IJ; Movsas B; Kretzler A
Pract Radiat Oncol; 2022; 12(4):e329-e338. PubMed ID: 35219879
[TBL] [Abstract] [Full Text] [Related]
16. Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling.
Sementino E; Kadariya Y; Cheung M; Menges CW; Tan Y; Kukuyan AM; Shrestha U; Karchugina S; Cai KQ; Peri S; Duncan JS; Chernoff J; Testa JR
Mol Cancer Res; 2022 May; 20(5):699-711. PubMed ID: 35082167
[TBL] [Abstract] [Full Text] [Related]
17. schisandrin B suppresses osteosarcoma lung metastasis
Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
[TBL] [Abstract] [Full Text] [Related]
18. Carboplatin and nab-paclitaxel chemotherapy with or without atezolizumab as front-line management for treatment-naïve metastatic nonsquamous non-small cell lung cancer with PD-L1 staining: a retrospective study.
Xu B; Cheng H; Li K; Lv Y; Zeng X; Liu T; Yu W; Guo W
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3029-3038. PubMed ID: 34973080
[TBL] [Abstract] [Full Text] [Related]
19. Malignant pleural mesothelioma co-opts BCL-X
Xu D; Liang SQ; Yang Z; Yang H; Bruggmann R; Oberhaensli S; Berezowska S; Marti TM; Hall SRR; Dorn P; Kocher GJ; Schmid RA; Peng RW
Cell Death Dis; 2021 Apr; 12(4):406. PubMed ID: 33859162
[TBL] [Abstract] [Full Text] [Related]
20. TNIK Is a Therapeutic Target in lung Squamous Cell Carcinoma and Regulates FAK Activation through merlin.
Torres-Ayuso P; An E; Nyswaner KM; Bensen RC; Ritt DA; Specht SI; Das S; Andresson T; Cachau RE; Liang RJ; Ries AL; Robinson CM; Difilippantonio S; Gouker B; Bassel L; Karim BO; Miller CJ; Turk BE; Morrison DK; Brognard J
Cancer Discov; 2021 Jun; 11(6):1411-1423. PubMed ID: 33495197
[TBL] [Abstract] [Full Text] [Related]
[Next]
